NEW ZEALAND GAZETTE, No. 10

2 FEBRUARY 2006

Pneumococcal vaccine; except in oral vaccines for the prophylaxis of bacterial complications of colds

Podophyllotoxin; for internal use; for external use for the treatment of anogenital warts; for other external use in medicines containing more than 1%

Podophyllum emodi; for internal use; for external use for the treatment of anogenital warts; for other external use in medicines containing more than 20% of podophyllin

Podophyllum peltatum; for internal use; for external use for the treatment of anogenital warts; for other external use in medicines containing more than 20% of podophyllin

Polyacrilamide; in injections or implantations for tissue augmentation or cosmetic use

Polylactic acid; in injections or implantations for tissue augmentation or cosmetic use

Poractant alfa

Posaconazole

Pramocaine

Pregabalin

Pregnenolone

Prilocaine; for injection except when used as a local anaesthetic by a dental therapist; except when specified elsewhere in the Schedule

Prochlorperazine; except when specified elsewhere in the Schedule; except when sold for the treatment of nausea associated with emergency contraception by pharmacists or nurses accredited to sell levonorgestrel for emergency contraception

Promethazine; except when specified elsewhere in the Schedule

Propamidine; except for ophthalmic use

Propantheline

Protamine sulfate

Quinisocaine

Sabadilla; except when specified elsewhere in the Schedule

Sevelamer

Solifenacin

Strontium ranelate

Strychnos spp

Tenofovir

Terlipressin

Thenyldiamine; except when specified elsewhere in the Schedule

Thiomesterone

Thiourea; except in medicines containing 0.1% or less

Treprostinil

Trichloroacetic acid; except for external use in medicines containing 12.5% or less for the treatment of warts other than anogenital warts

Trimeprazine; except when specified elsewhere in the Schedule

Triprolidine; except when specified elsewhere in the Schedule

Vardenafil

Ximelagatran

Schedule 2

Restricted Medicines

*Alclometasone; for dermal use in medicines containing 0.05% or less and in packs containing not more than 30 grams which have received the consent of the Minister or the Director-General to their distribution as restricted medicines and are sold in the manufacturer’s original pack

Azatadine; for oral use

Brompheniramine; for oral use except when specified elsewhere in the Schedule

Buclizine; for oral use

Chlorpheniramine; for oral use except when specified elsewhere in the Schedule

Ciclopirox; for dermal use in medicines containing more than 2%

Clemastine; for oral use

*Clobetasone; for dermal use in medicines containing 0.05% or less and in packs containing not more than 30 grams which have received the consent of the Minister or the Director-General to their distribution as restricted medicines and are sold in the manufacturer’s original pack

Cyclizine; for oral use

Cyproheptadine; for oral use

Dexchlorpheniramine; for oral use except when specified elsewhere in the Schedule

Diclofenac; in solid dose form containing 25 milligrams or less and more than 12.5 milligrams per dose form in packs of not more than 30 tablets or capsules

Dimenhydrinate; for oral use except when specified elsewhere in the Schedule

Dimethindene; for oral use

Diphenhydramine; for oral use except when specified elsewhere in the Schedule

Diphenylpyraline; for oral use except when specified elsewhere in the Schedule

Doxylamine; for oral use except when specified elsewhere in the Schedule

Erythryl tetranitrate

*Fluconazole; for oral use in medicines which have received the consent of the Minister or the Director-General to their distribution as restricted medicines and are sold in the manufacturer’s original pack containing 150 milligrams or less as a single dose for the treatment of vaginal candidiasis

Fluorides; in pastes, gels or powders for cleaning the teeth containing more than 0.1%

Glyceryl trinitrate; for oral or sublingual use

Haemophilus influenzae vaccine; in oral vaccines for the prophylaxis of bacterial complications of colds

Hyoscine butylbromide; for oral use in medicines containing not more than 10 milligrams per dose form and in packs containing not more than 20 tablets or capsules

Ketotifen; for ophthalmic use in medicines containing 0.025% or less

Mannityl hexanitrate

Methdilazine; for oral use

Orlistat; in medicines containing 120 milligrams or less per dose form for the purpose of weight control

Pheniramine; for oral use except when specified elsewhere in the Schedule

Phenyltoloxamine; for oral use

Pneumococcal vaccine; in oral vaccines for the prophylaxis of bacterial complications of colds

Podophyllotoxin; for external use for the treatment of warts other than anogenital warts in medicines containing 1% or less and more than 0.5%

Podophyllum emodi; for external use for the treatment of warts other than anogenital warts in medicines containing 20% or less and more than 10% of podophyllin

Podophyllum peltatum; for external use for the treatment of warts other than anogenital warts in medicines containing 20% or less and more than 10% of podophyllin